Skip to main content

Table 2 Sensitivity analysis of the prevalence of hyperuricemia among type 2 diabetes mellitus patients in Africa

From: Prevalence of hyperuricemia among type 2 diabetes mellitus patients in Africa: a systematic review and meta-analysis

Study omitted

Estimate

95% CI

Arersa et al. (2020)

27.86

26.45–29.27

Woyesa et al. (2017)

26.94

25.54–28.34

Woldeamlak et al. (2019)

26.96

25.54–28.37

Ogbera et al. (2010)

27.83

26.36–29.30

Uwakwe et al. (2014)

27.05

25.69–28.42

Akande et al. (2007)

28.47

27.07–29.86

Donkeng et al (2021)

27.39

26.03–28.76

Choukem et al. (2016)

26.36

24.94–27.77

Mirghani (2018)

28.20

26.81–29.60

Gobusamang et al. (2019)

27.34

25.94–28.75

Shokat et al. (2019)

27.79

26.40-29.17

Fennoun et al. (2020)

27.44

26.06–28.82

Barry et al. (2021)

27.32

25.95–28.70

Fouad et al. (2016)

26.51

25.04–27.99

Combined

27.40

26.04–28.75